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Healthcare and Substance Use Service Accessibility and Barriers for Syringe Service Program
(SSP) Participants in Manchester, NH
Background
Opioid use is a prevalent topic in New Hampshire, as our state has one of the highest
rates of death from opioid overdose in the country (CDC, 2018). The current literature
surrounding people who inject drugs’ (PWID) experiences and needs indicate a lack of access to
preventative care and treatment resources. However, many of these inquiries are not specific to
New Hampshire’s PWID (Artenie, 2015; Al-Tayyib, 2015) but instead focus on the population as
a whole. Decreased resources are even more prevalent due to COVID (Nolte et al., 2020). One of
the goals of Syringe Services Programs (SSPs) is to engage participants in connecting with
services and offering low barrier access to resources. SSPs offer sterile supplies, education, and
support to PWID (CDC, 2016). SSPs demonstrate reductions in overdose deaths, communicable
disease transmission (HIV and Hepatitis C), and infection rates such as endocarditis and
abscesses (CDC, 2017). Fifty percent of participants who engage with an SSP reduce their use
after engagement and are five times more likely to enter a substance use treatment program
(CDC, 2017). SSPs also know how to engage PWID with compassion, as these persons face
discrimination in the community (Kidorf, 2011). Although the benefits of SSPs are clear there is
little knowledge about factors that enable or constrain SSP participants’ healthcare engagement.
PWID often face discrimination in the inpatient setting due to their drug use and bloodborne diseases (Maffina et al., 2013). Effective engagement of PWID is even more critical given
the greater physiological vulnerability to infectious disease including HIV and Hepatitis C
(HCV). PWID are more likely to leave against medical advice (AMA) which often leads them to

HEALTHCARE AND SUBSTANCE USE SERVICE ACCESS

3

not completing recommended treatment and therefore at higher risk for health issues to progress
to a chronic or more life-threatening stage (Biancarelli et al., 2019).
Experiencing discrimination within healthcare can negatively impact engagement in care
and receipt of effective treatment. When PWID feel as though they are being discriminated
against they are less likely to honestly disclose information about their health and their drug use
and are less likely to stay engaged in harm reduction services (Henwood et al., 2014). Some fear
the loss of control over their prescribed opioid to the point of wanting to avoid the healthcare
realm altogether, obtaining heroin and opioids from the street to achieve relief instead (Marie,
2014). Although multiple sources describe the difficulties, few effective interventions have been
identified to integrate into the inpatient setting to address these concerns.
Community-based resources are often the healthcare setting of choice for PWID.
Supervised injection facilities, rarely available within the US, provide non-judgmental treatment
and a safer environment for PWID not only physically, but socially and emotionally. These
facilities provide integrated care with access to counseling and social services, which is not
typically found in the inpatient setting (Lang, et al., 2013). Use of harm reduction approaches,
like supervised injection facilities, demonstrates to PWID that providers value, care for, respect,
and dignify patients as individuals. Harm reduction strategies result in providers celebrating any
positive change toward better health and used positive reinforcement as a building block in the
patient-provider relationship (Rosenburg & Davis, 2013). In a harm reduction approach,
providers recognize that PWID require support during any transition toward risk reduction.
Evidence for harm reduction approaches has been primarily built up in community-based
settings. Thus, connecting PWID to community programs increases the chance in continuity of
care for these patients secondary to the support received in such settings.
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The current literature outlines multiple factors that lead to negative interaction for
PWID in healthcare. Firstly, PWID often feel that their pain is not well managed, which is
associated with feelings of isolation, shame, humiliation, and poor communication with the
healthcare team (Marie, 2014). Other PWID on chronic opioid therapy also reported fear of
losing control of their prescribed opioid, wanting to hide treatment from others, and feeling
stigmatized when receiving treatment for pain. (Marie, 2014).
Negative experiences for PWID with healthcare and are missed opportunities to support
positive change. PWIDs report some service providers are unable to provide effective services
due to a lack of resources and education (Maffina et al., 2009). In most cases, there is mutual
mistrust between the provider and the patient, which creates a barrier for treatment and
communication. PWID have cited poor interaction with service providers as the main reason for
avoiding care (Maffina et al., 2013). PWID describe being denied access or resources as
stigmatizing and embarrassing, leading to internalization and reaction to stigma (Paquette et al.,
2018). PWID associated this stigmatization with delayed and substandard care of overdoses and
injection-related infections (Paquette et al., 2018).
Positive interactions between healthcare professionals and patients are essential in
engaging PWID in high quality care. When PWID feel welcomed in the hospital they are more
inclined to connect to resources. Establishing rapport is important for healthcare professionals
when communicating with all patients, but especially important with PWID due to the
disproportion of health disparities they face. Patient outcomes are optimized when care is
delivered in a non-judgmental and respectful manner (Paquette et al., 2018).
Although the majority of interactions PWID face within healthcare literature have been
described as negative, this highlights the great potential to address and promote positive
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interactions. Key factors in positive interactions include transparent and continuous honest
communication between patients and their health caregivers (Marie, 2014). PWID value
relationships with family, extended family, and their supports who they perceive view their
circumstances optimistically (Small et al., 2009). Despite these findings, providers may be less
likely to engage family and friends of PWID than other clients. Providers could benefit from
recognizing the power they have and therefore remain and ally and advocate for their clients.
Once a provider-client relationship is established it is maintained. A key component of
maintaining a positive provider-client relationship is by understanding that abstinence-only goals
during recovery are not realistic for every PWID (Small et al., 2009). A critical time to show
support for a PWID are during those times in which they may still be moderately using. Support
being withheld during this transition time between moderate use and abstinence, could actually
put the patient at risk for isolation from resources and support (Hawk et al., 2017). Instead, Hawk
and colleagues (2017) recommend positive reinforcement to be rewarded as an encouraging
incentive to continue to strive towards sobriety.
Community-based resources are preferred by PWID as a safe and welcoming place to
receive care and connection to counseling and other social services (Lang et al., 2013). Needle
exchange programs are becoming more prevalent here in NH as well as across the country and
have been shown to incentivize clients to seek primary care (Lang et al., 2013). Although
equitable care is often perceived more by patients in the outpatient setting, these strategies have
also seen positive results when integrated into the inpatient setting. For instance, PWID found
lower levels of using when they were offered multidisciplinary support services for substance
misuse in the inpatient setting (Wakeman et al., 2017).
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The primary aim of the study was to identify the health service needs of SSP participants
in Manchester, NH. To answer this question more accurately, it was broken into five subquestions:
1. What healthcare services are SSP participants accessing and what is their
satisfaction with those services?
2. What substance use services are SSP participants accessing and what is their
satisfaction with those services?
3. What barriers to accessing medical care do SSP participants face?
4. How did COVID affect this access to substance use services and healthcare
services?
5. Is there an association between accessing substance use (SU) and healthcare
services with length of engagement with an SSP?

Methods and Materials
This study was conducted between November 2020 and May 2021. The study was
University of New Hampshire IRB approved (#8386) and funded by the UNH Collaborative
Research Excellence (CoRE) program. A Qualtrics survey was administered to up to two
hundred participants of fours SSP in New Hampshire. Data collection is still ongoing at one site.
This study focuses on Manchester subset of data that engaged Queen City Exchange participants.
These surveys were completed in November and December 2020. Criteria for inclusion was
being at least 18 years of age and actively participating in an SSP. The Qualtrics survey took
approximately 15 to 20 minutes and was administered on a tablet. The survey included audio-
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computer assisted self-interview (ACASI), as this is best practice to accommodate those who
would prefer questions read for them, including low literacy individuals. The survey explored
items including syringe access, use of safe supplies, healthcare services, substance use, substance
use services, infection prevention, overdose/naloxone, and demographics. A $20 gift card was
provided for participation in the study. From January to April of 2021, data analysis was
conducted on SPSS Statistics. Additional analysis and graphing were completed on Excel. A chi
square test was utilized to test associations between SSP engagement and accessing services.
Results
Recruitment for this study yielded 81 participants (demographics listed in Table 1). The
majority of our participants were 26-35 years old (n=26, 41.9%).
Table 1
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The survey questioned participants regarding the healthcare services accessed (Table 2).
The most utilized non-emergent service was primary care (n=46, 56.7%), while the most
accessed emergent services with the emergency department (n=55, 67.9%).
Table 2
Healthcare Services Accessed (N=81)

%

n

Accessed ANY Services

91.3%

74

Accessed ANY Non-Emergency Care

71.6%

58

Primary care

56.7

46

Mental health services (counselling, psychiatry)

46.9

38

Health department (Manchester or Nashua)

24.6

20

Health clinic or van (ie Healthcare for the Homeless)

24.6

20

Accessed ANY Emergency Care

75.3%

61

Emergency Department

67.9

55

Walk in/ Urgent care

42.0

34

The survey questioned participants if they felt satisfied with the support received by these
services (Figure 1). Overall, participants were the most satisfied with the support received from
primary care (n=36, 78.2%), and the least satisfied with health clinics or vans (n=8, 40%).

HEALTHCARE AND SUBSTANCE USE SERVICE ACCESS

9

Despite being the most accessed, the ED had lower satisfaction with support received (n=34,
61.8%).
Figure 1

The survey also questioned participants regarding substance use services accessed and if
they felt satisfied with the support received by these services. Table 3 describes Non-MOUD
substance use services accessed by participants. For the non-medication-based group, these
services were not utilized as much as healthcare services medical detox (n=34, 42%), peer-help
groups (n=29, 35.8%), and counseling (n=28, 34.6%) were accessed the most.
Table 3
Non-MOUD Substance Use
Services Accessed (N=81)
Medical detox
Peer help groups (NA, AA,
SMART Recovery, etc.)
Counselling one on one
Residential Programs (ex. 28
days)
Recovery residence/sober
house

%

n

42.0
35.8

34
29

34.6
29.6

28
24

21.0

17
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Figure 2 represents the satisfaction rates of those using non-MOUD services. Overall,
the percentages of those satisfied with these services is not extremely high, with each around 5060%.
Figure 2

Table 4 describes MOUD substance use services accessed by participants. Prescribed
MOUD. has strong evidence in reducing illicit opioid use, mortality, drug-related HIV risk
behaviors and crime and has been shown to be very cost-effective (Hall et al., 2021). 42 of 81
participants accessed any kind of medication, with buprenorphine pills (n=31, 35.8%) and
methadone (n=21, 27.2%) being the more utilized options.
TableMOUD
4
Substance Use
Services Accessed (N=81)
Buprenorphine (pills) from a
prescriber
Methadone from a clinic
Buprenorphine (injectable)
from a prescriber
Naltrexone (injectable)
Accessed ANY Medication

%

n

35.8

31

27.2
13.6

21
11

12.3
51.9

10
42
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Figure 3 represents the satisfaction rates of those using MOUD services. Overall, beside
the naltrexone shots also known as Vivitrol, the satisfaction with these services is mixed
(although there was a small sample size). We also have to consider that our SSP participants are
engaging with an exchange potentially because these services did not lead to abstinence or
desired control of their use.
Figure 3

The next portion of the results examines barriers SSP participants face when accessing
medical care (Table 5). The 3 most common responses were a lack of transportation (n=27,
33.3%), being afraid of disrespect because of their drug use (n=24, 29.6%), and someone besides
a medical professional treated their issue or they treated themselves (n=24, 29.6%).

Table 5
Number of Participants
(N=81)
No transportation

%

n

33.3

27
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Number of Participants
(N=81)
Afraid of disrespect because I
use drugs
Someone else treated me (not
a doctor or nurse) or I treated
myself
Could not pay
Treated poorly in the past
Lack of trust in doctors and
nurses
Don’t care about taking care
of myself at this time
Unsure where to go
Unable to get care because
“to high or too drunk”
Did not want to be seen at
clinic
Clinic hours inconvenient
Didn’t have childcare

%
29.6

12
n
24

29.6

24

24.7
18.5

20
15

16.0
16.0
14.8
14.8
13.6
11.1
2.5

13
13
12
12
11
9
2

Figure 4 shows how many barriers each participant faces. 21 of our 81 participants
experience no barriers to healthcare. However, the majority of the participants have at least 1
barrier to accessing medical care, with some experiencing as many as 9 of the barriers.

Figure 4
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Statistical analysis was used to see if there was an association between accessing
healthcare services and months engaging with an SSP. Only 64 participants were used, as this
was a fill-in answer and some of the responses were not specific enough to categorize. Access of
non-emergent services was the focus, as it is well documented in the literature that PWID often
utilize emergency service. To look for an association, a chi square test was performed despite this
being a smaller sample size. There was not a relation between engagement in an SSP and
accessing non-emergent care or primary care.
Statistical analysis was also used to see if there was an association between accessing
substance use services and months engaging with an SSP. Overall, MOUD is utilized less than
others. The literature documents this could be due to barriers such as negative MOUD
perceptions, fear of experiencing stigma, cost and a perceived lack of flexibility. The chi square
test found that there was not a relation between engagement in an SSP and accessing non-MOUD
and MOUD services (Table 6).
Table 6
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We also included how participants felt COVID has affected their access to services (Table
7). The category least affected was naloxone, with 81.7% (n=58) stating there was no change in
access. Syringes, healthcare services, and substance use services had similar results, with
healthcare services having the highest percentage of participants reporting access becoming more
difficult.
Table 7
Since COVID-19
how has your access
changed to access:
Sterile Syringes
(n=61)
Healthcare Services
(n=66)
Substance Use
Services (n=67)
Naloxone (n=71)

Harder to Access %

No Change %

Easier to Access %

21.3

63.9

14.8

39.4

56.1

4.5

32.8

58.2

9.0

7.0

81.7

11.3

Discussion
Primary care is effective for addressing many of the complex health needs of PWID, as
they can provide screenings, vaccinations, PreP, MOUD, and can foster a long-term relationship.
PWID engaged in primary care are more likely to initiate and maintain MOUD and abstain from
drug use (Motavelli et al., 2021). This is consistent with our results, as these participants felt the
most supported by primary care. However, emergency medical services are utilized more often,
as we also saw in our data with 55 of 81 (67.9%) participants utilizing this service. In this study
as well, the ED was utilized more, but participants were not as satisfied. The literature
documents that while emergency departments have developed innovative protocols to address the
unmet needs of PWID accessing emergency services, they are not designed or resourced for
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delivering preventive services, providing long-term management of SUD, or addressing social
needs (Motavelli et al., 2021).
MOUD, especially methadone and buprenorphine, has strong evidence in reducing illicit
opioid use, mortality, drug-related HIV risk behaviors and crime and has been shown to be very
cost-effective. The most reported barriers overall were negative perceptions, fear of experiencing
stigma, cost, and a perceived lack of flexibility around OST (Hall et al., 2021). The participants
in this study were also not as satisfied with these services. As previously stated, one must also
consider that the SSP participants are engaging with an exchange potentially because these
services did not lead to abstinence or desired control of their use.
For barriers, 60 of 81 (74%) participants face at least one barrier to care, the most
common barriers: Fear of judgement, lack of transportation, and self-treatment. COVID has also
negatively impacted this population’s access to resources (Nolte et al., 2020). Despite the lack of
statistical relation between length of SSP engagement and access to non-emergent, primary care,
non-MOUD and MOUD services, the sample size was small and therefore is not as reliable. The
nature of this association and what is means for future research still needs to be further analyzed.
SSPs are in a unique position of interacting with PWID on a regular basis. These
programs have to power to engage more participants in health services such as primary care,
MOUD, and other resources. These referrals to primary care can result in better long-term
management of their complex needs and a reduction in complications.
There are a few limitations to this study. The environment the surveys were taken in may
have affected the results. Due to the COVID-19 pandemic data collection occurred outdoors, so
participants may have spent less time on their answers in order to finish. Some participants also
had to be excluded for incomplete surveys. The statistical analyses may also not be as accurate,
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as only 64 participants could be included in the analysis due to some missing data. A larger
sample size would have yielded more accurate results in the analysis portion of this study. While
this was one of the largest groups for all the SSP sites surveyed, responses were still less than the
preferred amount for the chi square test, as only 64 of the participants’ responses for length of
time were able to be deciphered.
Conclusions
This study effectively engaged SSP participants to assess factors that enable or constrain
their healthcare involvement. Primary care was the most utilized non-emergent service in the
study. PWID also felt the most supported by primary care services. It is recommended that
PWID regularly engage with primary care for screenings, MOUD, and other long-term
management. While the emergency department was used more frequently, emergency services
cannot regularly provide long-term management of PWID’s complex needs. While MOUD is
documented in the literature to reduce illicit opioid use, these medications are underutilized.
Common barriers to healthcare include fear of judgment, lack of transportation, and selftreatment. COVID-19 has also affected access to resources, which public health officials and
SSPs should take into consideration for the future. In terms of association between length of SSP
engagement and accessing services, more research is needed with a larger sample size.
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